202 related articles for article (PubMed ID: 15535257)
21. Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):244-8. PubMed ID: 18752842
[TBL] [Abstract][Full Text] [Related]
22. [Value of high-field MR diffusion-weighted MR imaging in the diagnosis of endometrial carcinoma].
Wang LX; Zhou CW; Ouyang H
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):849-53. PubMed ID: 20137351
[TBL] [Abstract][Full Text] [Related]
23. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
[TBL] [Abstract][Full Text] [Related]
24. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.
Felix AS; Stone RA; Bowser R; Chivukula M; Edwards RP; Weissfeld JL; Linkov F
Int J Gynecol Cancer; 2011 Jul; 21(5):877-84. PubMed ID: 21666484
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging of endometrial cancer and clear cell cancer.
Manabe T; Hirose Y; Kiryuu T; Koudo H; Hoshi H
J Comput Assist Tomogr; 2007; 31(2):229-35. PubMed ID: 17414759
[TBL] [Abstract][Full Text] [Related]
26. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
[TBL] [Abstract][Full Text] [Related]
27. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
Brustmann H
Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
[TBL] [Abstract][Full Text] [Related]
28. Intramural carcinomas of the uterine corpus: a clinicopathological study.
Kuwashima Y; Kurosumi M; Kasamatsu T; Shiromizu K; Kishi K
In Vivo; 1997; 11(3):253-60. PubMed ID: 9239520
[TBL] [Abstract][Full Text] [Related]
29. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
30. Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix.
Zaloudek C; Hayashi GM; Ryan IP; Powell CB; Miller TR
Int J Gynecol Pathol; 1997 Jan; 16(1):52-9. PubMed ID: 8986533
[TBL] [Abstract][Full Text] [Related]
31. Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
Matrai CE; Pirog EC; Ellenson LH
Int J Gynecol Pathol; 2018 Sep; 37(5):405-413. PubMed ID: 29019871
[TBL] [Abstract][Full Text] [Related]
32. Metastatic endometrial endometrioid carcinoma with clear cell changes to the breast: a case report.
Farghaly H
Ann Diagn Pathol; 2013 Feb; 17(1):127-30. PubMed ID: 22048014
[TBL] [Abstract][Full Text] [Related]
33. Advanced endometrial cancer with serous metastasis in a 17-year-old.
Cohn DE; Resnick KE; Ramirez NC; Morrison CD
Gynecol Oncol; 2006 May; 101(2):356-9. PubMed ID: 16499956
[TBL] [Abstract][Full Text] [Related]
34. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
35. Clear Cell Lesions of the Mullerian System: Not Always That "Clear"!
Wawire J; Lawrence WD; Quddus MR
Int J Surg Pathol; 2019 Dec; 27(8):884-886. PubMed ID: 30917732
[No Abstract] [Full Text] [Related]
36. [Pathological diagnosis of ovarian cancer].
Yamabe H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():507-10. PubMed ID: 15535297
[No Abstract] [Full Text] [Related]
37. cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer.
Chen Y; Yao Y; Zhang L; Li X; Wang Y; Zhao L; Wang J; Wang G; Shen D; Wei L; Zhao J
Exp Mol Pathol; 2011 Aug; 91(1):373-84. PubMed ID: 21540026
[TBL] [Abstract][Full Text] [Related]
38. High-grade endometrial carcinomas - strategies for typing.
Soslow RA
Histopathology; 2013 Jan; 62(1):89-110. PubMed ID: 23240672
[TBL] [Abstract][Full Text] [Related]
39. Cytopathology of ovarian lesions: the intraoperative approach.
Jiménez-Ayala M; Jiménez-Ayala Portillo B
Monogr Clin Cytol; 2011; 20():60-76. PubMed ID: 21160249
[No Abstract] [Full Text] [Related]
40. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]